Efficacy of CD40 Agonists Is Mediated by Distinct cDC Subsets and Subverted by Suppressive Macrophages.
Aleksandar MurgaskiMáté KissHelena Van DammeDaliya KanchevaIsaure VanmeerbeekJiri KeirsseEva HadadiJan BrughmansSana M ArnoukAhmed E I HamoudaAyla DebraekeleerVictor BosteelsYvon ElkrimLouis BoonSabine HovesNiels VandammeSofie DeschoemaekerSophie JanssensAbhishek Dinkarnath GargGreetje Vande VeldeMartina SchmittnaegelCarola H RiesDamya LaouiPublished in: Cancer research (2022)
This work highlights the temporal roles of different dendritic cell subsets in promoting CD8+ T-cell-driven responses to CD40 agonist therapy in cancer.